We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG Says Medicare Drug Rebates Could Save Billions; CMS Disagrees
OIG Says Medicare Drug Rebates Could Save Billions; CMS Disagrees
September 13, 2013
If drugmakers were required to pay rebates on Medicare Part B drugs, similar to those they pay for Medicaid drugs, Medicare could save billions of dollars a year, according to a recently published study by the HHS Office of the Inspector General (OIG).